Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 29, 2011 | December 21, 2012 |
| AbbVie Inc.ABBV · Entity 2800 | Director | March 31, 2025 | April 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 29, 2011 · Filed December 21, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 49,432 |
Reported balance
After 2011-12-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2011-12-29 · Gift · Disposed 24,982 · Balance 49,432 F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16.
AbbVie Inc.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 386,479 |
Reported balance
After 2025-03-31 transaction · row 1
1 source rowRow 1 · 2025-03-31 · Gift · Disposed 2,450 · Balance 386,479 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 18, 2007 Filed Sep 20, 2007 01:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without part value | 27,000 | $52.26 | $1,411,020.00 |
DisclosureSEC source: 0001104659-07-070109 · a4.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,410 Read SEC document |
| September 18, 2007 Filed Sep 20, 2007 01:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 55,800 | $52.25 | $2,915,550.00 |
DisclosureSEC source: 0001104659-07-070109 · a4.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,410 Read SEC document |
| September 18, 2007 Filed Sep 20, 2007 01:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 105,367 | $41.03 | $4,323,387.13 |
DisclosureSEC source: 0001104659-07-070109 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 549,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2007 Filed Sep 20, 2007 01:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 144,633 | $45.45 | $6,573,396.29 |
DisclosureSEC source: 0001104659-07-070109 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2007 Filed Sep 20, 2007 01:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $52.58 | $5,258.00 |
DisclosureSEC source: 0001104659-07-070110 · a4.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,210 Read SEC document |
| September 18, 2007 Filed Sep 20, 2007 01:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $52.57 | $26,285.00 |
DisclosureSEC source: 0001104659-07-070110 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,310 Read SEC document |
| September 18, 2007 Filed Sep 20, 2007 01:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,700 | $52.56 | $89,352.00 |
DisclosureSEC source: 0001104659-07-070110 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,810 Read SEC document |
| September 18, 2007 Filed Sep 20, 2007 01:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,600 | $52.55 | $241,730.00 |
DisclosureSEC source: 0001104659-07-070110 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,510 Read SEC document |
| September 18, 2007 Filed Sep 20, 2007 01:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,800 | $52.54 | $304,732.00 |
DisclosureSEC source: 0001104659-07-070110 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,110 Read SEC document |
| September 18, 2007 Filed Sep 20, 2007 01:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,000 | $52.53 | $210,120.00 |
DisclosureSEC source: 0001104659-07-070110 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,910 Read SEC document |
| September 17, 2007 Filed Sep 20, 2007 01:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-07-070109 · a4.xml · derivative · entry 31 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,833 Underlying: Common shares · 10,000 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Option Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 17, 2007 Filed Sep 20, 2007 01:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $52.26 | $15,678.00 |
DisclosureSEC source: 0001104659-07-070109 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,210 Read SEC document |
| September 17, 2007 Filed Sep 20, 2007 01:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 9,700 | $52.25 | $506,825.00 |
DisclosureSEC source: 0001104659-07-070109 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,510 Read SEC document |
| September 17, 2007 Filed Sep 20, 2007 01:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 10,000 | $45.45 | $454,488.00 |
DisclosureSEC source: 0001104659-07-070109 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 54,180 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · derivative · entry 21 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,833 Underlying: common shares · 54,180 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 22,220 | $0.00 Strike: $45.80 | $0.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · derivative · entry 20 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 22,220 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,000 | $52.27 | $209,080.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 17 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,210 Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,600 | $52.26 | $240,396.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 16 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,210 Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 67,800 | $52.25 | $3,542,550.00 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 15 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,810 Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 54,180 | $45.45 | $2,462,415.98 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2007 Filed Sep 17, 2007 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 22,220 | $45.80 | $1,017,598.23 |
DisclosureSEC source: 0001104659-07-069589 · a4.xml · nonDerivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 641 | $0.00 Strike: $45.80 | $0.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · derivative · entry 32 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,220 Underlying: common shares · 641 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 6,681 | $0.00 Strike: $39.50 | $0.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · derivative · entry 31 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 6,681 shares Expires 2010-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 72,130 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · derivative · entry 30 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353 Underlying: common shares · 72,130 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $52.52 | $47,268.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 29 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,320 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $52.51 | $47,259.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 28 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,220 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,450 | $52.50 | $181,125.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 27 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,120 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $52.49 | $5,249.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 26 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,570 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,300 | $52.48 | $68,224.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 25 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,670 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $52.47 | $47,223.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 24 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,970 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,200 | $52.45 | $62,940.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 23 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,870 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $52.44 | $5,244.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 22 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,070 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $52.43 | $10,486.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 21 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,170 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $52.41 | $5,241.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 20 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,370 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $52.40 | $10,480.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 19 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,470 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,700 | $52.39 | $141,453.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 18 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,670 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 600 | $52.38 | $31,428.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 17 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,370 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $52.37 | $20,948.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 16 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,970 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,700 | $52.36 | $298,452.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 15 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,370 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,900 | $52.35 | $204,165.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,070 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 21,300 | $52.34 | $1,114,842.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,970 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 37,000 | $52.33 | $1,936,210.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 12 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,270 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 14,300 | $52.32 | $748,176.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 11 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,270 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 10,600 | $52.31 | $554,486.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441,570 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 30,250 | $52.30 | $1,582,075.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,170 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 12,390 | $52.29 | $647,873.10 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,420 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 14,000 | $52.28 | $731,920.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,810 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 13,000 | $52.27 | $679,510.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 508,810 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,300 | $52.26 | $329,238.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 521,810 Read SEC document |
| September 13, 2007 Filed Sep 17, 2007 22:48 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 21,100 | $52.25 | $1,102,475.00 |
DisclosureSEC source: 0001104659-07-069588 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,110 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.